Literature DB >> 2382607

Recovery of regional myocardial dysfunction after successful coronary angioplasty early after a non-Q wave myocardial infarction.

H Suryapranata1, P W Serruys, K Beatt, P J De Feyter, M van den Brand, J Roelandt.   

Abstract

More aggressive therapy has been suggested for patients who have a non-Q wave myocardial infarction (MI) because of the frequency of subsequent unstable angina, recurrent MI, and high mortality rate compared to patients with Q wave MI. The present study was undertaken to investigate the effect of coronary angioplasty on regional myocardial function of the infarct zone in patients with angina early after a non-Q wave MI. The study population consisted of 36 patients undergoing successful coronary angioplasty within 30 days of a non-Q wave MI, in whom sequential left ventricular angiograms of adequate quality were obtained before the initial procedure and at follow-up angiography. The global ejection fraction increased significantly from 60 +/- 9% to 67 +/- 6% (p = 0.0003). This significant increase in the global ejection fraction was primarily due to a significant improvement in the regional myocardial function of the infarct zone. The results of the present study show not only that ischemic attacks early after a non-Q wave MI may lead to prolonged regional myocardial dysfunction but more important that this depressed myocardium has the potential to achieve normal contraction after successful coronary angioplasty.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2382607     DOI: 10.1016/0002-8703(90)90068-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  1 in total

1.  Increase in serum cardiac myosin light chain I associated with elective percutaneous transluminal coronary angioplasty in patients with ischemic heart disease.

Authors:  H Tanaka; K Gotoh; Y Yagi; T Tanaka; K Yamashita; T Suzuki; S Hirakawa
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.